Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-06-25 5:13 pm Purchase |
2020-06-15 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 43,599 9.990% |
43,599 (New Position) |
Filing History |
| 2020-06-22 5:23 pm Purchase |
2020-06-18 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 3,224,172 11.000% |
1,787,743 (+124.46%) |
Filing History |
| 2020-06-22 5:17 pm Purchase |
2020-06-16 | 13G | Xenon Pharmaceuticals Inc. XENE |
BIOTECHNOLOGY VALUE FUND L P | 3,516,851 10.100% |
860,794 (+32.41%) |
Filing History |
| 2020-06-22 4:36 pm Purchase |
2020-06-11 | 13G | Curis, Inc. CRIS |
BIOTECHNOLOGY VALUE FUND L P | 182,500 7.200% |
182,500 (New Position) |
Filing History |
| 2020-06-08 10:27 am Purchase |
2020-06-05 | 13G | Calliditas Therapeutics AB (publ) CALT |
BIOTECHNOLOGY VALUE FUND L P | 4,781,562 9.700% |
4,781,562 (New Position) |
Filing History |
| 2020-06-03 5:03 pm Purchase |
2020-06-01 | 13G | Merus N.V. MRUS |
BIOTECHNOLOGY VALUE FUND L P | 4,990,571 17.200% |
1,820,917 (+57.45%) |
Filing History |
| 2020-06-01 5:37 pm Sale |
2020-05-28 | 13G | BioLineRx Ltd. BLRX |
BIOTECHNOLOGY VALUE FUND L P | 781,062 11.800% |
-17,498 (-2.19%) |
Filing History |
| 2020-05-29 5:06 pm Purchase |
2020-05-19 | 13G | Surface Oncology, Inc. SURF |
BIOTECHNOLOGY VALUE FUND L P | 2,125,650 5.800% |
2,125,650 (New Position) |
Filing History |
| 2020-05-26 4:56 pm Sale |
2020-05-21 | 13G | Calithera Biosciences, Inc. CALA |
BIOTECHNOLOGY VALUE FUND L P | 354,532 10.100% |
-123,450 (-25.83%) |
Filing History |
| 2020-05-22 5:22 pm Purchase |
2020-05-12 | 13G | Sutro Biopharma, Inc. STRO |
BIOTECHNOLOGY VALUE FUND L P | 2,368,392 6.600% |
2,368,392 (New Position) |
Filing History |